Psyched Wellness LTD. Announces Insider Buying and Option Grant to Professor Nutt

Toronto, Ontario, November 18, 2020 – Psyched Wellness Ltd. (formerly Duncan Park Holdings Corporation) (CSE:PSYC, OTC Pink: DCNPF) (the “Company” or “Psyched”) a life sciences company focused on the production and distribution of artisanal functional and psychedelic mushrooms, is pleased to inform investors that since commencing trading on the CSE on October 22, 2020, certain management and board members have purchased common shares in the company on the open market.

Jeffrey Stevens, CEO – purchased 250,000 Common Shares at an average cost of $0.1216

Terry Booth, Director – purchased 262,500 Common Shares at an average cost of $0.13

Michael Nederhoff, Chairman – purchased 100,000 Common Shares at an average cost of $0.11

The Company has also issued 500,000 options at $0.145 to Professor David Nutt for his increased capacity as a member of the board of directors.

“I am proud to share this news, I believe it demonstrates to our shareholders that we as a team, are all fully committed to growing Psyched Wellness,” Said Jeff Stevens, CEO of the Company. “I am not aware of many other companies where the management and board purchased shares in the open market within the first month of trading.”